Study of the clinical Management of bipolar disease - WAVE bd
Study identifier:NIS-NEU-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Multinational ambispective study of the clinical management and burden of Bipolar Disorder (WAVE bd Study)
Medical condition
Bipolar Disorders
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
2965
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Apr 2010
Primary Completion Date: 01 Jun 2011
Study Completion Date: 01 Jun 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patients diagnosed with Bipolar Disorder I or II (DSM-IV-TR) at any phase of the disorder with at least one mood event during the 12 months before the study start. | - |
| 2 Patients diagnosed with Bipolar Disorder I or II (DSM-IV-TR) at any phase of the disorder with at least one mood event during the 12 months before the study start receiving Seroquel extended release at some point during the retrospective period . | - |
Contacts
Investigators
Principal Investigator
Esteban Medina
Medical Department.AstraZeneca Spain
